AVE
Asset Logo

Avecho Biotechnology Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

5
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Avecho Biotechnology Ltd. engages in the development, production, sale, and licensing of products incorporating its patented platform technology, Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care and animal health and nutrition industries. The company is headquartered in Melbourne, Victoria. The firm develops and commercializes human and animal health products using its drug delivery system Tocopherol Phosphate Mixture (TPM). The firm's products pipeline includes Weaner Pig Starter TPM premix, Poultry TPM, Dairy TPM, Daptomycin, Propofol and Veterinary Applications. The firm's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Company’s Human Health segment covers delivery of pharmaceutical products through gels, injectables and patches. This segment focuses on the development of patches, including TPM/Oxymorphone, TPM/enhanced, and TPM/Oxycodone. The firm is also developing TPM to enhance feed efficiency and health of livestock. Its TPM products are commercialized under license Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

📈 Performance

Price History

-97.07%

1M

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.01

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in AVE

5

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in AVE

585 days
AVE investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

17%

50k - 100k

50%

Less than 50k

33%
👶 Age of investors

18 - 25

26 - 34

60%

35 - 90

40%
🙋 Legal gender of investors

Female

60%

Male

40%

Pearlers who invest in AVE also invest in...

Avecho Biotechnology Limited

AVENA

Avecho Biotechnology Ltd. engages in the development, production, sale, and licensing of products incorporating its patented platform technology, Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care and animal health and nutrition industries. The company is headquartered in Melbourne, Victoria. The firm develops and commercializes human and animal health products using its drug delivery system Tocopherol Phosphate Mixture (TPM). The firm's products pipeline includes Weaner Pig Starter TPM premix, Poultry TPM, Dairy TPM, Daptomycin, Propofol and Veterinary Applications. The firm's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Company’s Human Health segment covers delivery of pharmaceutical products through gels, injectables and patches. This segment focuses on the development of patches, including TPM/Oxymorphone, TPM/enhanced, and TPM/Oxycodone. The firm is also developing TPM to enhance feed efficiency and health of livestock. Its TPM products are commercialized under license Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

Find Out More

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

📊 Share price

$90.18 AUD

NULL AUSTRALIA

NULL BETA

A200

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

📊 Share price

$120.79 AUD

NULL AUSTRALIA

NULL BETA

ESGI

ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.

📊 Share price

$29.97 AUD

NULL GLOBAL

NULL SMART BETA

NULL ETHICAL

NULL THEMATIC

FAIR

FAIR.AX was created on 2017-11-27 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes Australian companies that have passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

📊 Share price

$18.55 AUD

NULL AUSTRALIA

NULL NEW ZEALAND

NULL ETHICAL

NULL THEMATIC

NULL SUSTAINABLE

Want more shares? Try these...

📊 Share price

$0.00 AUD

📊 Share price

$0.00 AUD

Auctus Investment Group Ltd. primary focus is to invest into companies and platforms operating in growth sectors. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-08-10. The firm is focused on opportunities across private equity, infrastructure and operating real-estate. The company invests in growth sectors with tailwinds and significant potential to scale. The firm provides access to these private market opportunities via investment funds to wholesale, family office, and institutional investors.

📊 Share price

$0.92 AUD

AVADA Group Ltd. engages in the provision of traffic management and ancillary service. The company is headquartered in Brisbane, Queensland. The company went IPO on 2021-12-17. The firm operates through three segments: Queensland Traffic Management, New South Wales Traffic Management, and Victoria Traffic Management. Queensland Traffic Management contains entities which operate in the Queensland geography. New South Wales Traffic Management contains entities which operate in the New South Wales geography. Victoria Traffic Management contains entities which operate in the Victorian geography. The firm provides services to government clients and major contractors in the civil infrastructure and maintenance sector. Its businesses include Verifact Traffic, A2O Traffic Solutions, D&D Traffic Management, Platinum Traffic Services, Traffic Marshal, Construct Traffic, TRAFFIC MANAGEMENT PEOPLE (TMP) and Linemark Traffic Control.

📊 Share price

$0.70 AUD
Compare
Add to watchlist